Brandon Eldredge, Chief New Clinical Business Officer
Brandon Eldredge is the Chief New Clinical Business Officer at Mass General Brigham. In this role, he is responsible for defining, analyzing, building and launching new clinical business initiatives across the system.
Prior to his role at Mass General Brigham, Brandon held leadership positions in strategy, business development, mergers and acquisitions, and partnerships in the healthcare and technology industries. Previous roles have included Senior Vice President, Corporate Strategy and Development at Syneos Health (previously inVentiv Health) and Chief Financial Officer for the Mobility and Services business of Aptiv PLC (now Motional). Brandon has also held various corporate development roles at Thermo Fisher Scientific and he advised clients as part of Barclays Capital's healthcare investment banking group.
Brandon graduated with a B.S. in Business Management from Babson College.